Waylan Bessler
Impact in
Papers in
- Neurology 16
- Neurofibromatosis and Schwannoma Cases 15
- Neuroblastoma Research and Treatments 3
-
- Protein Tyrosine Phosphatases 2
- Signaling Pathways in Disease 2
- Co-authors
- David A. Ingram (12 shared papers)Laura E. Mead (3 shared papers)Jamie Case (4 shared papers)Daniel N. Prater (2 shared papers)Laura S. Haneline (2 shared papers)Mervin C. Yöder (2 shared papers)Hilary White (2 shared papers)M. Reza Saadatzadeh (1 shared paper)
- Journals
- Human Molecular Genetics (5 papers)Blood (3 papers)Molecular Cancer Therapeutics (1 paper)Science Advances (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesUnited KingdomNorway
In The Last Decade
Waylan Bessler
21 papers receiving 974 citations
Peers
Comparison fields: 5 of 81
- Neurology 253
- Genetics 152
- Oncology 207
- Cell Biology 123
- Molecular Biology 503
Countries citing papers authored by Waylan Bessler
This map shows the geographic impact of Waylan Bessler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waylan Bessler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waylan Bessler more than expected).
Fields of papers citing papers by Waylan Bessler
This network shows the impact of papers produced by Waylan Bessler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waylan Bessler. The network helps show where Waylan Bessler may publish in the future.
Co-authors
The 25 scholars most cited alongside Waylan Bessler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 412 | |
| 2 | 2009 | 100 | |
| 3 | 2008 | 83 | |
| 4 | 2008 | 66 | |
| 5 | 2010 | 58 | |
| 6 | 2019 | 55 | |
| 7 | 2008 | 44 | |
| 8 | 2007 | 28 | |
| 9 | 2013 | 27 | |
| 10 | 2013 | 24 | |
| 11 | 2016 | 22 | |
| 12 | 2012 | 14 | |
| 13 | 2021 | 14 | |
| 14 | 2016 | 13 | |
| 15 | 2019 | 10 | |
| 16 | 2020 | 6 | |
| 17 | 2021 | 3 | |
| 18 | Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of Nf1-Deficient Mice | 2019 | 2 |
| 19 | 2025 | 1 | |
| 20 | 2020 | 1 |
About Waylan Bessler
Waylan Bessler is a scholar working on Neurology, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 21 papers that have together received 984 indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (15 papers), Mast cells and histamine (5 papers), Peptidase Inhibition and Analysis (5 papers), Sarcoma Diagnosis and Treatment (4 papers), Neuroblastoma Research and Treatments (3 papers), Protein Tyrosine Phosphatases (2 papers), Urticaria and Related Conditions (2 papers) and Signaling Pathways in Disease (2 papers). The work is most often cited by research in Neurology (253 citations), Genetics (152 citations), Oncology (207 citations), Cell Biology (123 citations) and Molecular Biology (503 citations). Waylan Bessler has collaborated with scholars based in United States, United Kingdom and Norway. Frequent co-authors include David A. Ingram, Laura E. Mead, Jamie Case, Daniel N. Prater, Laura S. Haneline, Mervin C. Yöder, Hilary White, M. Reza Saadatzadeh, Simon J. Conway and Julie A. Mund. Their work appears in journals such as Human Molecular Genetics, Blood, Molecular Cancer Therapeutics, Science Advances and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.